Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Therapie
|
September 1, 2005
[Meningococcal serogroup C vaccine: a pharmacovigilance point of view]
Haleh Bagheri, Mireille Gony, Jean-Louis Montastruc
Fundamental & Clinical Pharmacology
|
May 7, 2021
Lacosamide-induced personality changes: An unexpected adverse effect
Jacques Hamard, Mathieu Rigal, Mireille Gony, et al.
Clinical Neuropharmacology
|
June 5, 2003
Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs
Mireille Gony, Maryse Lapeyre-Mestre, Jean-Louis Montastruc, et al.
Therapie
|
March 16, 2021
[Amiodarone or COVID induced-pneumopathy: One train can hide another one!]
Mélanie Vasseur, Marine Tambon, Mireille Gony, et al.
Therapie
|
September 16, 2004
[Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data]
Jean-Louis Montastruc, Maryse Lapeyre-Mestre, Mireille Gony, et al.
Therapie
|
August 10, 2012
[Could we improve notification of adverse drugs reactions in hospital? Assessment of 5 years of network PharmacoMIP's activities]
Julien Jacquot, Mireille Gony, Dominique Baudrin, et al.
Drug Safety
|
April 20, 2010
Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study
Mireille Gony, Kattalin Badie, Agnès Sommet, et al.
European Addiction Research
|
January 25, 2014
A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions
Maryse Lapeyre-Mestre, Mireille Gony, Alfonso Carvajal, et al.
Fundamental & Clinical Pharmacology
|
May 25, 2007
Coxibs: evolution of prescription's behaviour in France
Julie Biga, Mireille Gony, Robert Bourrel, et al.
Therapie
|
June 24, 2006
[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]
Jean-Louis Montastruc, Agnès Sommet, Pascale Olivier, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Therapie
|
September 1, 2005
[Meningococcal serogroup C vaccine: a pharmacovigilance point of view]
Haleh Bagheri, Mireille Gony, Jean-Louis Montastruc
Fundamental & Clinical Pharmacology
|
May 7, 2021
Lacosamide-induced personality changes: An unexpected adverse effect
Jacques Hamard, Mathieu Rigal, Mireille Gony, et al.
Clinical Neuropharmacology
|
June 5, 2003
Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs
Mireille Gony, Maryse Lapeyre-Mestre, Jean-Louis Montastruc, et al.
Therapie
|
March 16, 2021
[Amiodarone or COVID induced-pneumopathy: One train can hide another one!]
Mélanie Vasseur, Marine Tambon, Mireille Gony, et al.
Therapie
|
September 16, 2004
[Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data]
Jean-Louis Montastruc, Maryse Lapeyre-Mestre, Mireille Gony, et al.
Therapie
|
August 10, 2012
[Could we improve notification of adverse drugs reactions in hospital? Assessment of 5 years of network PharmacoMIP's activities]
Julien Jacquot, Mireille Gony, Dominique Baudrin, et al.
Drug Safety
|
April 20, 2010
Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study
Mireille Gony, Kattalin Badie, Agnès Sommet, et al.
European Addiction Research
|
January 25, 2014
A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions
Maryse Lapeyre-Mestre, Mireille Gony, Alfonso Carvajal, et al.
Fundamental & Clinical Pharmacology
|
May 25, 2007
Coxibs: evolution of prescription's behaviour in France
Julie Biga, Mireille Gony, Robert Bourrel, et al.
Therapie
|
June 24, 2006
[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]
Jean-Louis Montastruc, Agnès Sommet, Pascale Olivier, et al.
Page
of 1